Snus lobby reaches Riksdag, Ekot ties M lawmaker to industry-linked groups, Sweden’s nicotine model faces funding questions

• Ekot reports that Jesper Skalberg Karlsson has appeared in campaigns and cooperated with groups linked to the tobacco industry while arguing for more permissive snus policy.
• Skalberg Karlsson told Ekot that those organisations were not known to him "to one hundred percent" in terms of what they do.
• The dispute tracks a larger split between public-health authorities and snus advocates over whether Sweden’s low smoking rate is caused by snus or merely coincides with high nicotine use.
• The story shifts attention from one politician’s optics to the funding and access of advocacy groups shaping nicotine policy in Stockholm.

Jesper Skalberg Karlsson of the Moderate Party has been one of the Swedish parliament’s most vocal advocates for looser rules on snus, the oral tobacco product long treated as part of Sweden’s exceptional nicotine debate. Now Sveriges Radio Ekot reports that he has also lectured for and cooperated with organisations linked to the tobacco industry, including appearing in a campaign for snus.

According to Ekot’s investigation, the same politician who has pushed a more permissive line in the Riksdag has moved in the orbit of advocacy groups with an interest in normalising nicotine products. Skalberg Karlsson told Ekot that he did not know those organisations and what they do "to one hundred percent." He also argued, against the line taken by the Public Health Agency of Sweden, that snus played an important role in getting Swedes to stop smoking. That disagreement matters because Sweden’s nicotine policy has increasingly been sold abroad as a public-health success story: low cigarette smoking, high use of snus and nicotine pouches, and a political class willing to describe substitution as progress.

The fight is not only over health outcomes but over who gets to define the evidence. Public-health agencies have warned that reduced smoking does not settle the question of broader nicotine dependence, especially when new products widen the market beyond former smokers. Industry-linked groups and their allies point to Sweden’s low smoking rates and lower rates of some smoking-related diseases compared with much of Europe. Politicians then translate those claims into tax policy, product regulation and messaging, often with the same talking points circulating between trade bodies, campaign groups and parliamentary offices.

That gives funding and access unusual weight. A network does not need many seats in the Riksdag if it can supply ready-made arguments, host seminars, offer platforms and wrap commercial interests in the language of harm reduction. Stockholm has seen this pattern before in other regulated sectors: agencies produce cautious reports, lobby groups package selective evidence, and elected officials present the result as common sense modernisation. In the snus debate, the commercial upside is plain enough. Every argument that frames nicotine pouches and snus as public-health tools also protects a large domestic market and opens room for lighter regulation.

Sweden’s reputation as the European outlier on tobacco has made the policy fight larger than one MP’s judgment about whom he shares a stage with. If the country’s model is being used to influence rules at home and abroad, the basic questions are prosaic: who pays for the campaigns, who drafts the briefs, which offices take the meetings, and how often the same organisations appear behind supposedly independent claims. Ekot’s reporting places one politician inside that circuit. The campaign photo was the easy part; the invoices and guest lists are usually elsewhere.

Källor: Sveriges Radio Ekot